Timing and heterogeneity of mutations associated with drug resistance in metastatic cancers
about
Cancer Evolution and the Limits of Predictability in Precision Cancer MedicineColorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology ApproachThe challenges of tumor genetic diversity.Modeling Tumor Clonal Evolution for Drug Combinations DesignQuantifying Clonal and Subclonal Passenger Mutations in Cancer Evolution.Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition.Differential selective pressure alters rate of drug resistance acquisition in heterogeneous tumor populations.Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers.A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity.Multi-scale Modeling in Clinical Oncology: Opportunities and Barriers to Success.Evolutionary scalpels for dissecting tumor ecosystems.Universal Asymptotic Clone Size Distribution for General Population Growth.Genetic background and evolution of relapses in aggressive B-cell lymphomas.Evolutionary dynamics and significance of multiple subclonal mutations in cancer.Academically led clinical trials: challenges and opportunities.The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy.Construction and analysis of gene-gene dynamics influence networks based on a Boolean model.Modeling the Subclonal Evolution of Cancer Cell Populations.Non-coding RNA networks in cancer.From Chemotherapy to Combined Targeted Therapeutics: In Vitro and in Vivo Models to Decipher Intra-tumor Heterogeneity.Implications of cancer evolution for drug development.Clinical significance of intratumor heterogeneity for gynecological carcinoma.
P2860
Q26767415-F00D57AA-3ACE-4063-A7EB-56C2D0228431Q28647615-00839828-D865-4272-9C25-B87142F3EE58Q30241056-0DF89745-7905-4F37-A284-2BBB195E7C4EQ33590430-D9B42319-B142-48E7-BEDD-40BBB789204DQ35909370-24028586-31A2-4445-A748-581ECE69E7ECQ36925503-DD4E44FB-89C9-43CD-ACB1-EC5629A0A7CCQ37397222-71BBFE00-B597-4FCB-B9F7-7CD69918AE07Q38833684-CBD5CF2F-B8B1-4123-80DB-1C3ABFC65956Q38843089-40B9BD4A-12FC-42E3-8324-DB7C6804D08FQ38888255-A7AE74A9-0CA0-4973-BD24-22C2D6153B35Q39030938-B19180F6-D3ED-43D2-BD17-684D7B96C0FEQ39264185-7EA43419-5C3A-4306-85CE-382CC5EAEC8EQ39336821-81AB8D42-3170-4AB9-A8AF-DBAAD1D4959FQ39399379-1474DD5E-F430-4BC2-BCB4-5F18706B7679Q43245004-A9A1DA2E-AA38-486D-9F66-897154F91C25Q47102996-22CEB48E-D9F2-4C08-8194-6D1F1CDC96F7Q49185456-97257914-1C9A-4E30-9600-9F5BBAC60899Q49541273-C8F4A011-701D-449D-A895-FF99B4BA4E82Q49689803-0C4F63B4-638D-49E2-8F5F-52ADF748B2E5Q50351390-E43226BE-2A7A-4141-8632-E555C1E39AB9Q52875535-7F1D3253-3078-47AA-8557-8FBB24BB03DDQ55034894-A0B17DC5-1B99-43D9-A360-D3181A249D78
P2860
Timing and heterogeneity of mutations associated with drug resistance in metastatic cancers
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Timing and heterogeneity of mu ...... sistance in metastatic cancers
@ast
Timing and heterogeneity of mu ...... sistance in metastatic cancers
@en
Timing and heterogeneity of mu ...... sistance in metastatic cancers
@nl
type
label
Timing and heterogeneity of mu ...... sistance in metastatic cancers
@ast
Timing and heterogeneity of mu ...... sistance in metastatic cancers
@en
Timing and heterogeneity of mu ...... sistance in metastatic cancers
@nl
prefLabel
Timing and heterogeneity of mu ...... sistance in metastatic cancers
@ast
Timing and heterogeneity of mu ...... sistance in metastatic cancers
@en
Timing and heterogeneity of mu ...... sistance in metastatic cancers
@nl
P2860
P356
P1476
Timing and heterogeneity of mu ...... sistance in metastatic cancers
@en
P2093
Martin A Nowak
P2860
P304
15964-15968
P356
10.1073/PNAS.1412075111
P407
P50
P577
2014-10-27T00:00:00Z